Predictive factors for residual disease in subsequent hysterectomy following conization for CINIII

被引:54
|
作者
Lu, CH [1 ]
Liu, FS [1 ]
Tseng, JJ [1 ]
Ho, ESC [1 ]
机构
[1] Taichung Vet Gen Hosp, Dept Obstet & Gynecol, Taichung 40705, Taiwan
关键词
CINIII; conization; endocervical curettage; residual disease;
D O I
10.1006/gyno.2000.5949
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The aim of this study was to determine predictive factors for post-cone residual disease in subsequent hysterectomy for CIN III. Methods. From June 1994 to June 1999, 120 patients with CIN III who received hysterectomy within 6 months of conization regardless of marginal status were identified from 1450 conization cases. The demographic features and pathologic parameters were analyzed for the predictive rate of post-cone residual disease. Results. Age greater than or equal to 50 years and parity greater than or equal to5 were significant factors associated with residual disease. The incidence of residual disease was 56.5 and 29.3% in patients greater than or equal to 50 and <50 years, respectively, and 61.8 and 36.0% in patients with parity <greater than or equal to>5 and <5. Post-cone endocervical curettage (ECC) and multiple-quadrant disease were the only pathologic predictive factors identified. The incidence of residual disease was 64.6 and 29.2% in patients with positive ECC and negative ECC, respectively, and 48.4 and 25.9% in patient with multiple-quadrant disease and one- or two-quadrant disease. Other pathologic parameters, including endocervical margins, ectocervical margins, endocervical gland involvement, and depth of conization, were not predictive of residual disease. When ECC was combined individually with age, endocervical margins, or multiple-quadrant disease, there was no increase of positive predictive rate; Conclusions. (1) Age 50 years or more and parity <greater than or equal to>5 were two demographic features that predicted post-cone residual disease. (2) ECC and multiple-quadrant disease were the only pathologic parameters that predicted post-cone residual disease. (3) With the appropriate application of the predictive factors, post-cone hysterectomy may be further decreased. (C) 2000 Academic Press.
引用
收藏
页码:284 / 288
页数:5
相关论文
共 50 条
  • [31] Is There Any Predictor for Residual Disease After Cervical Conization With Positive Surgical Margins for HSIL or Microinvasive Cervical Cancer?
    Tasci, Tolga
    Turan, Taner
    Ureyen, Isin
    Karalok, Alper
    Kalyoncu, Rukiye
    Boran, Nurettin
    Tulunay, Gokhan
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2015, 19 (02) : 115 - 118
  • [32] Preoperative pathologic findings associated with residual disease at radical hysterectomy in women with stage IA2 cervical cancer
    Suri, Anuj
    Frumovitz, Michael
    Milam, Michael R.
    dos Reis, Ricardo
    Ramirez, Pedro T.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (01) : 110 - 113
  • [33] Adjuvant hysterectomy for treatment of residual disease in patients with cervical cancer treated with radiation therapy
    T Ota
    N Takeshima
    T Tabata
    K Hasumi
    K Takizawa
    British Journal of Cancer, 2008, 99 : 1216 - 1220
  • [34] Factors associated with residual disease in the central cone
    Carvajal Pliego, Juan Manuel
    Torres Mendoza, Rodolfo Saul
    Gonzalez Enciso, Aaron
    Perez-Montiel, Delia
    Lasa, Federico
    Cantu de Leon, David
    GACETA MEXICANA DE ONCOLOGIA, 2015, 14 (01): : 21 - 27
  • [35] Adjuvant hysterectomy for treatment of residual disease in patients with cervical cancer treated with radiation therapy
    Ota, T.
    Takeshima, N.
    Tabata, T.
    Hasumi, K.
    Takizawa, K.
    BRITISH JOURNAL OF CANCER, 2008, 99 (08) : 1216 - 1220
  • [36] Reexcision for positive margins in breast cancer: A predictive score of residual disease
    Mimouni, Myriam
    Lecuru, Fabrice
    Rouzier, Roman
    Lotersztajn, Noemie
    Heitz, Denis
    Cohen, Julien
    Fauconnier, Arnaud
    Huchon, Cyrille
    SURGICAL ONCOLOGY-OXFORD, 2015, 24 (03): : 129 - 135
  • [37] Treatment of residual disease following neoadjuvant therapy in breast cancer
    Heater, Natalie K.
    Somayaji, Khyati
    Gradishar, William
    JOURNAL OF SURGICAL ONCOLOGY, 2024, 129 (01) : 18 - 25
  • [38] Cellular dormancy in minimal residual disease following targeted therapy
    Ruth, Jason R.
    Pant, Dhruv K.
    Pan, Tien-chi
    Seidel, Hans E.
    Baksh, Sanjeethan C.
    Keister, Blaine A.
    Singh, Rita
    Sterner, Christopher J.
    Bakewell, Suzanne J.
    Moody, Susan E.
    Belka, George K.
    Chodosh, Lewis A.
    BREAST CANCER RESEARCH, 2021, 23 (01)
  • [39] Cellular dormancy in minimal residual disease following targeted therapy
    Jason R. Ruth
    Dhruv K. Pant
    Tien-chi Pan
    Hans E. Seidel
    Sanjeethan C. Baksh
    Blaine A. Keister
    Rita Singh
    Christopher J. Sterner
    Suzanne J. Bakewell
    Susan E. Moody
    George K. Belka
    Lewis A. Chodosh
    Breast Cancer Research, 23
  • [40] Risk factors for residual lesions after total hysterectomy in patients with high-grade cervical intraepithelial neoplasia
    Wang, Jing
    Wang, Chao
    Su, Tao
    BMC WOMENS HEALTH, 2024, 24 (01)